Clinical trial
Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis
NCT06709079 is registered in ClinicalTrials.gov with Cheng Lei as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Effect and Mechanism of Aescine Sodium in the Treatment of Allergic Rhinitis
- Lead sponsor
- Cheng Lei
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2024
- Completion date
- September 30, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
allergic rhinitis